Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Henderson

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Antiviral Research|January 12, 2013
Resolution of the interaction mechanisms and characteristics of non-nucleoside inhibitors of hepatitis C virus polymeraseJohan Winquist, Eldar Abdurakhmanov, Vera Baraznenok, et al.
Frontiers in Neuroscience|April 16, 2026
Altering PTPRD via genetics or pharmacology modulates 3xTg-AD mouse neurofibrillary pathologyGeorge R Uhl, Balaji Kannan, Sarah Jung, et al.
Pharmaceutical Research|September 14, 2004
Use of biophysical characterization in preformulation development of a heavy-chain fragment of botulinum serotype B: evaluation of suitable purification process conditionsFrank K Bedu-Addo, Catharine Johnson, Shanthini Jeyarajah, et al.
Combinatorial Chemistry & High Throughput Screening|June 22, 2006
Successful screening of large encoded combinatorial libraries leading to the discovery of novel p38 MAP kinase inhibitorsAxel Metzger, David J Diller, Tsung H Lin, et al.
Journal of Pharmaceutical Sciences|May 24, 2007
Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvantsChristina Vessely, Tia Estey, Theodore W Randolph, et al.
Journal of Translational Medicine|May 11, 2018
Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711Erik Lindström, Biljana Rizoska, Ian Henderson, et al.
Vaccine|September 7, 2010
Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B)Jeffry D Shearer, Michelle L Vassar, William Swiderski, et al.
The Journal of Obstetrics and Gynaecology Research|December 4, 2020
Quantifying CD138+ cells in the endometrium to assess chronic endometritis in women at risk of recurrent pregnancy loss: A prospective cohort study and rapid reviewMichael P Rimmer, Katherine Fishwick, Ian Henderson, et al.
Plant Physiology|May 22, 2016
Regulation of MicroRNA-Mediated Developmental Changes by the SWR1 Chromatin Remodeling ComplexKyuha Choi, Juhyun Kim, Sebastian Y Müller, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 18, 2020
Early versus delayed urinary catheter removal after hysterectomy: A systematic review and meta-analysisMichael P Rimmer, Ian Henderson, Stephen D Keay, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Antiviral Research|January 12, 2013
Resolution of the interaction mechanisms and characteristics of non-nucleoside inhibitors of hepatitis C virus polymeraseJohan Winquist, Eldar Abdurakhmanov, Vera Baraznenok, et al.
Frontiers in Neuroscience|April 16, 2026
Altering PTPRD via genetics or pharmacology modulates 3xTg-AD mouse neurofibrillary pathologyGeorge R Uhl, Balaji Kannan, Sarah Jung, et al.
Pharmaceutical Research|September 14, 2004
Use of biophysical characterization in preformulation development of a heavy-chain fragment of botulinum serotype B: evaluation of suitable purification process conditionsFrank K Bedu-Addo, Catharine Johnson, Shanthini Jeyarajah, et al.
Combinatorial Chemistry & High Throughput Screening|June 22, 2006
Successful screening of large encoded combinatorial libraries leading to the discovery of novel p38 MAP kinase inhibitorsAxel Metzger, David J Diller, Tsung H Lin, et al.
Journal of Pharmaceutical Sciences|May 24, 2007
Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvantsChristina Vessely, Tia Estey, Theodore W Randolph, et al.
Journal of Translational Medicine|May 11, 2018
Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711Erik Lindström, Biljana Rizoska, Ian Henderson, et al.
Vaccine|September 7, 2010
Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B)Jeffry D Shearer, Michelle L Vassar, William Swiderski, et al.
The Journal of Obstetrics and Gynaecology Research|December 4, 2020
Quantifying CD138+ cells in the endometrium to assess chronic endometritis in women at risk of recurrent pregnancy loss: A prospective cohort study and rapid reviewMichael P Rimmer, Katherine Fishwick, Ian Henderson, et al.
Plant Physiology|May 22, 2016
Regulation of MicroRNA-Mediated Developmental Changes by the SWR1 Chromatin Remodeling ComplexKyuha Choi, Juhyun Kim, Sebastian Y Müller, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 18, 2020
Early versus delayed urinary catheter removal after hysterectomy: A systematic review and meta-analysisMichael P Rimmer, Ian Henderson, Stephen D Keay, et al.
Pageof 9